Comments on “Role SGLT2 inhibitor therapy in patients with transthyretin cardiac amyloidosis: a GRADE assessed systematic review and meta-analysis”

Acta cardiologica. Supplementum 2026

View at publisher
Authors: Ankur Sharma, Varshini Vadhithala, Arun Kumar, Sushma Verma, Sushma Narsing Katkuri
DOI: 10.1080/00015385.2025.2610027
Cited by: 0
References: 8

Abstract

To the EditorThe recent GRADE-assessed systematic review and meta-analysis evaluating sodium-glucose cotransporter 2 (SGLT2) inhibitors in transthyretin cardiac amyloidosis addresses a clinically i...

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Statistical Methods in Epidemiology Parathyroid Disorders and Treatments

Publication details

Journal / source
Acta cardiologica. Supplementum
Publisher
Informa UK Limited
Volume
81
Issue
2
Pages
184–185
Publication date
3 January 2026
Language
EN